You are here: Industry Insights > Treatment

News List

Skyhawk, Genentech Enter Exclusive Multi-target RNA Alliance contractpharma
July 17, 2019
Will leverage SkySTAR platform to discover and develop small molecule treatments for oncology and neurological disease targets.
Company Reaches $1.4 Billion Settlement in Opioid Treatment Investigation drugs
July 16, 2019
Company Reaches $1.4 Billion Settlement in Opioid Treatment Investigation.
Syndax Pharma Gets IND Clearance for Leukemia Treatment drugs
July 12, 2019
Will begin Phase 1/2 trial for targeted Menin inhibitor, SNDX-5613, in patients with relapsed/refractory acute leukemias.
Addicted to Video Games? This Treatment Might Help drugs
July 11, 2019
Know someone who just can't put down the controller in the middle of online games like Fortnite or League of Legends?
New Vaccine in the Treatment of Rheumatoid Arthritis biospectrumasia
July 09, 2019
CEL-SCI Collaborators Presents Data for New Vaccine in the Treatment of Rheumatoid Arthritis at the International Conference on Immunity and Immunochemistry Meeting Second Rheumatoid Arthritis vaccine discovered which acts alone and can complement the exi
FDA approves new treatment for refractory multiple myeloma worldpharmanews
July 05, 2019
FDA approves new treatment for refractory multiple myeloma.
ActoBio Therapeutics Progresses Diabetes Treatment to Next Study Stage americanpharmaceuticalreview
July 03, 2019
ActoBio Therapeutics has announced that it will progress to the next stage of the Phase Ib/IIa clinical trial for investigational drug AG019 for the treatment of early-onset type 1 diabetes (T1D).
FDA approves Alexion’s Soliris as first treatment for CNS disease NMOSD pharmaceutical-technology
July 01, 2019
Alexion Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has approved Soliris (eculizumab), a first-in-class complement inhibitor, for neuromyelitis optica spectrum disorder (NMOSD) patients who are anti-aquaporin-4 (AQP4) anti
FDA approves first treatment for chronic rhinosinusitis with nasal polyps biospectrumasia
June 28, 2019
Patients who received Dupixent had statistically significant reductions in their nasal polyp size and nasal congestion compared to the placebo group
USPTO Allows Patent Claims for CBM BioPharma Application for Pancreatic Cancer Treatment americanpharmaceuticalreview
June 27, 2019
CBM BioPharma announced the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance and Issue Fee Due in CBM's patent application related to the treatment of pancreatic cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page